← Back to all trials
Recruiting
NCT06352619
Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial
Conditions: Ischemic Stroke, Acute
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 2000
Sponsor: The George Institute
Location: The George Institute for Global Health Sydney New South Wales
Summary
Several clinical trials have produced variable conclusions regarding the effects of intensive blood pressure (BP) lowering in post-EVT acute ischaemic stroke (AIS) patients. Although two trials indicate harm from very intensive target-based treatment (SBP \
Eligibility Criteria
Inclusion Criteria:
1. Age ≥18 years;
2. Use of endovascular therapy (EVT) within 24 hours of symptom onset or last known well according to local guidelines;
3. Sustained high systolic blood pressure ≥150 mmHg (2 readings \
Source: ClinicalTrials.gov (NCT06352619). StuddyBuddy aggregates publicly available trial information.
